Families Actively Improving Relationships (FAIR) for Stimulant Use Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
OSLC, Eugene, ORStimulant Use Disorder+3 MoreFamilies Actively Improving Relationships (FAIR) - Behavioral
Eligibility
16 - 30
All Sexes
What conditions do you have?
Select

Study Summary

This trial offers the potential to deliver a new outpatient prevention program to high-risk, young parents in order to help address the opioid and methamphetamine use disorders crisis in Oregon.

Eligible Conditions
  • Stimulant Use Disorder
  • Child Neglect
  • Opioid Use Disorder
  • Mental Health Disorder

Treatment Effectiveness

Study Objectives

5 Primary · 2 Secondary · Reporting Duration: Duration of the study, up to 4 years

Baseline to 24-months Post-Baseline
Mean Changes From Baseline in Parenting Behaviors as Assessed by the BCAP at 24-months Post-Baseline
Mean Changes in Drug Use Frequency and Severity from Baseline to 24-months Post-Baseline
Mean Changes in Mental Health Symptoms from Baseline to 24-months Post-Baseline
Year 4
Completion of Key Intervention Implementation Activities Over the Course of the Study
Costs Associated with Key Intervention Implementation Activities Over the Course of the Study
Descriptive Measures of FAIR Program Delivery
Month 9
Mean Levels of Client Satisfaction with Services at the End of Treatment

Trial Safety

Trial Design

2 Treatment Groups

Control
1 of 2
Pre-FAIR
1 of 2

Active Control

Experimental Treatment

240 Total Participants · 2 Treatment Groups

Primary Treatment: Families Actively Improving Relationships (FAIR) · No Placebo Group · N/A

Pre-FAIR
Behavioral
Experimental Group · 1 Intervention: Families Actively Improving Relationships (FAIR) · Intervention Types: Behavioral
Control
Behavioral
ActiveComparator Group · 1 Intervention: Standard Case Management and Referral · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: duration of the study, up to 4 years

Who is running the clinical trial?

Oregon Social Learning CenterLead Sponsor
31 Previous Clinical Trials
9,751 Total Patients Enrolled
Lisa Saldana, PhDPrincipal InvestigatorOregon Social Learning Center
3 Previous Clinical Trials
966 Total Patients Enrolled

Eligibility Criteria

Age 16 - 30 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have not used opioids improperly or used methamphetamine more than 3 times in the last year.

Frequently Asked Questions

Is it possible for me to register and participate in this experiment?

"Opioid addiction is a prerequisite for eligibility in this trial and participants must be between 16 to 30 years old. The study seeks to recruit approximately 240 patients." - Anonymous Online Contributor

Unverified Answer

Are there still openings available for participants in this clinical trial?

"The clinical trial is recruiting participants, as the information on clinicialtrials.gov states. This study went live on June 12th 2021 and was recently updated on May 19th 2022." - Anonymous Online Contributor

Unverified Answer

Does the study include any individuals under 25 years of age?

"Qualified applicants for this medical trial must be between the ages of 16 and 30. Additionally, there are a total of 274 clinical trials designed specifically to serve those under 18 years old and 816 studies tailored towards elderly patients over 65." - Anonymous Online Contributor

Unverified Answer

How many participants will be accepted for this research endeavor?

"Affirmative. According to the information listed on clinicaltrials.gov, this research project is currently in search of participants. This trial was initially posted back in June 12th 2021 and has been recently revised as of May 19th 2022 - with a total goal of recruiting 240 patients at one site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.